Products for regulating the degradation of collagen and methods for identifying same
CA 2500669 A1 · Owner: Shriners Hospital For Children · Inventors: Poole, A. Robin
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides products and methods for regulating the degradation of collagen, including type II collagen. Also encompassed are variants, inhibitors, and mimetics of type II collagen peptide fragments and inhibitors of the proteases producing these peptide fragments that are capable of modifying the degradation of collagen whereby the pathological effects of increased collagen destruction are reduced. In addition the present invention , provides methods for treating disease states wherein the disease state results directly or indirectly from the degradation of one or more collagen species. Furthermore, the present invention encompasses the screening of these peptide …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 30, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 30, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 30, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.